Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Wayland Group Corp. specializes in the cultivation and sale of both medical and recreational cannabis products, serving patients and consumers across Canada and on the international stage. Their product portfolio encompasses a diverse selection of cannabis strains, featuring varying levels of CBD, balanced cannabinoid profiles, and high THC content. These are marketed under several distinct brands, including Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann. Established in 2013, the company maintains its headquarters in Oakville, Canada, and operates as a subsidiary of Maricann Group Inc.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is 'cheap' on EV/EBITDA.